Term Name: angiogenesis inhibitor
Synonyms: angiogenesis antagonist, angiostatic agents, anti-angiogenic agent
Definition: An agent and endogenous substances that antagonize or inhibit the development of new blood vessels.
Ontology: Chebi [CHEBI:48422]

Relationships
is a type of: drug
inverse has_role: (-)-antofine (-)-matairesinol (-)-voacangine (1R,2S,3S,4S)-4-formyl-2-methoxy-3-[(2E)-6-methylhept-2-en-2-yl]cyclohexyl (2E)-3-(4-methoxyphenyl)acrylate (1S,2S,3S)-3-methoxy-2-[(2E)-6-methylhept-2-en-2-yl]-4-oxocyclohexanecarbaldehyde (2S,3S,4S)-2-methoxy-3-[(2E)-6-methylhept-2-en-2-yl]-4-(trifluoroacetyl)cyclohexanone (2S,3S,4S)-4-(1,1,1,3,3,3-hexafluoro-2-hydroxypropan-2-yl)-2-methoxy-3-[(2E)-6-methylhept-2-en-2-yl]cyclohexanone (2S,3S,4S)-4-(hydroxymethyl)-2-methoxy-3-[(2E)-6-methylhept-2-en-2-yl]cyclohexanone (2S,3S,4S)-4-acetyl-2-methoxy-3-[(2E)-6-methylhept-2-en-2-yl]cyclohexanone (4Z,7Z,10Z,12E,14S,16Z,19Z,21R)-dihydroxydocosahexaenoic acid 3PO AEE788 ageladine A amentoflavone ascochlorin ascofuranone aureothricin baicalein brivanib brivanib alaninate cafestol capsiate crenolanib deguelin diosmetin disulfiram EG00229 epoxytwinol A fumagillin GP369 herbacetin indirubin JQ1 kahweol lenalidomide leucosesterlactone leucosesterterpenone linifanib luminespib lupulone luteolin menadione meso-tetrakis(N-methyl-4-pyridyl)porphine tetrakis(p-toluenesulfonate) meso-tetrakis(N-methyl-4-pyridyl)porphine(4+) MP-A08 N-(5-{[(5-tert-butyl-1,3-oxazol-2-yl)methyl]sulfanyl}-1,3-thiazol-2-yl)piperidine-4-carboxamide N-[3-(aminomethyl)benzyl]acetamidine nintedanib nintedanib esylate O-(chloroacetylcarbamoyl)fumagillol oridonin PD-166866 PJ34 PJ34 hydrochloride pomalidomide quininib quininib hydrochloride rifampicin SB220025 SH-11037 sorafenib SU4312 sunitinib suramin suramin sodium tamoxifen tamoxifen citrate thalidomide thiolutin toluquinol trans-rhaponticin vatalanib vatalanib succinate wogonin